| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.39 | 0.04 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |